Literature DB >> 19818230

Vascular dementia: a review of recent evidence for prevention and treatment.

Howard S Kirshner1.   

Abstract

Vascular dementia is a common cause of late-life cognitive decline. Vascular risk factors, transient ischemic attacks, silent and clinically evident strokes, and ischemic changes on brain imaging studies are all associated with the development of dementia. Prevention of vascular dementia involves treatment of risk factors and the same preventive measures used to avoid heart attacks and strokes. Other treatments for vascular dementia, although promising, remain unproved.

Entities:  

Mesh:

Year:  2009        PMID: 19818230     DOI: 10.1007/s11910-009-0065-y

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  61 in total

1.  Executive function and magnetic resonance imaging subcortical hyperintensities in vascular dementia.

Authors:  D J Moser; R A Cohen; R H Paul; J S Paulsen; B R Ott; N M Gordon; S Bell; W M Stone
Journal:  Neuropsychiatry Neuropsychol Behav Neurol       Date:  2001 Apr-Jun

Review 2.  Cerebral microhemorrhage.

Authors:  Anand Viswanathan; Hugues Chabriat
Journal:  Stroke       Date:  2006-01-05       Impact factor: 7.914

Review 3.  Neurology of the vasculitides and connective tissue diseases.

Authors:  P M Moore; B Richardson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-07       Impact factor: 10.154

Review 4.  Central nervous system vasculitis.

Authors:  C Fieschi; M Rasura; A Anzini; M Beccia
Journal:  J Neurol Sci       Date:  1998-01-08       Impact factor: 3.181

5.  Silent brain infarcts and the risk of dementia and cognitive decline.

Authors:  Sarah E Vermeer; Niels D Prins; Tom den Heijer; Albert Hofman; Peter J Koudstaal; Monique M B Breteler
Journal:  N Engl J Med       Date:  2003-03-27       Impact factor: 91.245

6.  Statins and the risk of dementia.

Authors:  H Jick; G L Zornberg; S S Jick; S Seshadri; D A Drachman
Journal:  Lancet       Date:  2000-11-11       Impact factor: 79.321

7.  Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study.

Authors:  A Solomon; I Kåreholt; T Ngandu; B Winblad; A Nissinen; J Tuomilehto; H Soininen; M Kivipelto
Journal:  Neurology       Date:  2007-03-06       Impact factor: 9.910

8.  Donepezil in vascular dementia: a randomized, placebo-controlled study.

Authors:  D Wilkinson; R Doody; R Helme; K Taubman; J Mintzer; A Kertesz; R D Pratt
Journal:  Neurology       Date:  2003-08-26       Impact factor: 9.910

9.  Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

Authors:  G C Román; T K Tatemichi; T Erkinjuntti; J L Cummings; J C Masdeu; J H Garcia; L Amaducci; J M Orgogozo; A Brun; A Hofman
Journal:  Neurology       Date:  1993-02       Impact factor: 9.910

10.  Clinical features of subcortical arteriosclerotic encephalopathy (Binswanger disease).

Authors:  L R Caplan; W C Schoene
Journal:  Neurology       Date:  1978-12       Impact factor: 9.910

View more
  4 in total

1.  Inhibited Expression of α4β2 Nicotinic Acetylcholine Receptor in Blood Leukocytes of Chinese Patients with Vascular Dementia and in Blood Leukocytes as Well as the Hippocampus of Brain from Ischemic Rats.

Authors:  Yan Xiao; Liang Zhao; Shi-Xiang Kuang; Zhi-Zhong Guan
Journal:  Cell Mol Neurobiol       Date:  2016-02-08       Impact factor: 5.046

Review 2.  Nutrition and vascular dementia.

Authors:  L Perez; L Heim; A Sherzai; K Jaceldo-Siegl; A Sherzai
Journal:  J Nutr Health Aging       Date:  2012-04       Impact factor: 4.075

Review 3.  Is MRI better than CT for detecting a vascular component to dementia? A systematic review and meta-analysis.

Authors:  Rebecca Beynon; Jonathan A C Sterne; Gordon Wilcock; Marcus Likeman; Roger M Harbord; Margaret Astin; Margaret Burke; Alysson Bessell; Yoav Ben-Shlomo; James Hawkins; William Hollingworth; Penny Whiting
Journal:  BMC Neurol       Date:  2012-06-06       Impact factor: 2.474

Review 4.  Cannabinoids and Dementia: A Review of Clinical and Preclinical Data.

Authors:  Sebastian Walther; Michael Halpern
Journal:  Pharmaceuticals (Basel)       Date:  2010-08-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.